upcoming conferences, page-7

Just another bit to add. Dr Paul Watt is one of the five scientists on the Advisory Board!!

Ref - http://www.ibclifesciences.com/Peptide/overview.xml


Peptide R&D for Discovery, Preclinical and Development Scientists


Peptide Discovery & Development is a unique program that focuses exclusively on innovations in peptide design, discovery, selection and delivery with an emphasis on strategies to exploit protein-protein interactions, find new peptide-like molecular scaffolds and develop intracellular peptides to access previously "undruggable targets" and disease mechanisms.

Find current innovations in peptide research:

?Hear breaking data on three cell-permeable peptides as drugs and find strategies for modulating intracellular and previously "undruggable targets"
?Discover how peptides can be used as starting points to create novel scaffolds, as vectors/ligands for targeting specific cell types or as protein-protein interaction modulators
?Evaluate creative technologies and techniques for peptide discovery, selection and design to accelerate your lead discovery efforts
?Find new ways to get peptides inside cells, exploit uptake mechanisms, and enable peptide-mediated delivery of oligonucleotides, proteins or other cargoes
Scientific Advisory Board
?Jesse Z. Dong, Ph.D., Vice President, Compound Discovery, IPSEN
?Michael J. Gait, Ph.D., MRC Programme Leader, Laboratory of Molecular Biology, Medical Research Council, United Kingdom
?Hanjo Hennemann, Ph.D., Executive Director and Head of R&D, Nexigen GmbH, Germany
?Derek Maclean, Ph.D., Director, Chemistry, KAI Pharmaceuticals
?Paul Watt, Ph.D., CEO, Phylogica, Ltd, Australia